Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
| Number Sort descending | Exp. Date | Activity Code(s) | Title |
|---|---|---|---|
| PAR-24-043 | August 19, 2026 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
| PAR-24-045 | November 20, 2024 | R21 | Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-24-046 | November 20, 2024 | R21 | Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) |
| PAR-24-059 | January 8, 2027 | R01 | Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) |
| PAR-24-063 | August 19, 2026 | U44 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
| PAR-24-075 | December 29, 2026 | R01 | Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
| PAR-24-076 | December 29, 2026 | R01 | Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required) |
| PAR-24-077 | January 8, 2027 | R01 | Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional) |
| PAR-24-081 | March 14, 2026 | X01 | Omics Phenotypes Related to Down Syndrome for the INCLUDE Project (X01 Clinical Trial Not Allowed) |
| PAR-24-131 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) |
| PAR-24-132 | April 6, 2027 | R43/R44 | Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) |
| PAR-24-133 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) |
| PAR-24-134 | April 6, 2027 | R41/R42 | Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) |
| PAR-24-144 | January 8, 2027 | R16 | Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
| PAR-24-145 | January 8, 2027 | R16 | Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
| PAR-24-160 | May 8, 2027 | R01 | New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) |
| PAR-24-161 | May 8, 2027 | R21 | New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) |
| PAR-24-197 | July 17, 2026 | R03 | HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
| PAR-24-206 | August 14, 2024 | U54 | Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) |
| RFA-AG-25-002 | July 3, 2024 | U54 | Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional) |
BACK TO TOP